As the universe of exchange-traded funds (ETF) expands, investors are being thrust into a land of confusion. There are more than 100 different international ETFs to choose from right now. There are even three separate and unique ETFs that specialize in water. Where do investors turn?

The majority of ETF investors do not realize there are five biotech choices available for purchase. What is more amazing is that the public sees "biotech ETF" and assumes all five must be interchangeable; However, in the first 7 months of the year the biotech sector has been flat, but the five ETFs that track the sector have been all over the board. Read on as we delve a little deeper into biotech ETFs and the disparity in their returns.

Biotech Buyers Beware
I hate to be the bearer of bad news, but there is a drastic difference in ETFs that claim to track the same sector. The variations are very noticeable in the returns of the biotech ETFs in the first seven and a half months of the year. Of the five biotech ETFs the best performer year-to-date through August 16 was the SPDR S&P Biotech ETF (NYSE:XBI) with a gain of about 14%. On the opposite end of the spectrum, HOLDRS Biotech ETF (NYSE:BBH) had a loss of 12% in the same timeframe.

In monetary terms, a $100,000 investment in XBI at the beginning of the year would now be worth about $114,000 and the BBH investment a mere $88,000. The BBH must put together a 30% increase just to get to even with the XBI. Keep in mind this took place in less than eight months time.

Looking Inside the Sector
To put the numbers into perspective, the AMEX Biotech Index lost 0.3% and the S&P 500 was down 0.5% in the same period. Therefore the XBI greatly outperformed the benchmarks, and BBH was a clear laggard. The other three biotech ETFs had a much more muted start to the year: iShares NASDAQ Biotech ETF (NYSE:IBB) -1.8%, First Trust AMEX Biotech ETF (NYSE:FBT) -0.8%, and PowerShares Dynamic Biotech ETF (AMEX:PBE) 3.1%.

Stocks vs. ETFs
By delving further into the numbers and looking at all biotech stocks we follow (204 total), the case for a biotech ETF strengthens. Of the 204 biotech stocks, only 23% were able to outperform XBI. As a matter of fact, only 52% had better returns than the 12% loss of BBH.

So, why would anyone invest in a biotech stock if the odds are the ETF will be able to outperform over half the time? It is a combination of greed and perceived stock picking abilities. The greed factor comes in because investors are over confident and want to go for the big winners. There was a 2% chance investors could have picked a stock that doubled. Even though the odds are small, there is still the chance. (To learn more, see Master Your Trading Mindtraps.)

At the same time, two out of every three biotech stocks were in negative territory. Well, maybe investors do not need to get the stock that doubles, but they feel they can outperform even the best biotech ETF. There was an 18% chance the investor could have picked a stock that gained over 20%. However, the possibility of picking a stock that lost at least 20% came in at 41%. Again the numbers are not favoring stock picking.

How about the possibility of picking a biotech stock that gets hit with negative news and takes a massive hit? Unbelievably, 13% of all biotech stocks lost at least 50% in the first seven and a half months of 2007.

Inside the ETFs
The reason for the major differences in returns of the ETFs has to do with their composition. The top performer, XBI, is very diverse and its largest holding makes up less than 4% of the entire allocation. The underperformance on BBH can be directly linked to its top three holdings, which make up 75% of the entire portfolio. Genentech (NYSE:DNA) and Amgen (Nasdaq:AMGN) are the top two holdings and are considered mega-cap biotech names that have returns of -9.8% and -27.7%, respectively.

I would not consider BBH an investment option unless I had intentions of purchasing all three of its top holdings separately and therefore could do so with the single purchase of an ETF. However, nearly all investors turn to ETFs as an investment vehicle to eliminate stock-specific risk and that is clearly not the case with BBH.

Of the five biotech ETFs, two that stand out above the others are XBI and PBE, because both have exposure to the large-cap names as well as some of the "junior" biotech stocks. By giving the ETF exposure to the small-cap and mid-cap names, it allows for the probability of owning a big winner, but at the same time one or two big losers will not ruin the returns of the ETF.

ETFs Win This Round
Right now, ETFs are clearly the better choice in the biotech sector for risk averse investors who would like to gain a true exposure to the entire arena. However, keep in mind you must look at the components of all ETFs before you consider making a purchase.

For related reading, see An Inside Look At ETF Construction.

Looking to cook up a market-stomping stock portfolio? Check out our FREE report "7 Ingredients to Market Beating Stocks" and get started right now!

Related Articles
  1. Mutual Funds & ETFs

    ETF Analysis: United States Brent Oil Fund

    Learn more about the United States Brent Oil exchange-traded fund, the characteristics of the fund and the suitability and recommendations of it.
  2. Mutual Funds & ETFs

    ETF Analysis: ProShares Ultra Bloomberg Crude Oil

    Find out more about the ProShares Ultra Bloomberg Crude Oil ETF, the characteristics of UCO and the suitability and recommendations of UCO for investors.
  3. Mutual Funds & ETFs

    ETF Analysis: iShares MSCI Hong Kong

    Learn about the iShares MSCI Hong Kong fund, which invests in various equities of companies listed on the Hong Kong Stock Exchange.
  4. Mutual Funds & ETFs

    ETF Analysis: Vanguard Small-Cap Growth

    Take a close look at the Vanguard Small-Cap Growth ETF, which focuses on domestic small-cap equities with a fundamental growth strategy.
  5. Mutual Funds & ETFs

    ETF Analysis: First Trust Dorsey Wright Focus 5

    Take a closer look at the First Trust Dorsey Wright Focus 5 ETF, a unique and innovative fund of funds based on momentum and relative strength.
  6. Mutual Funds & ETFs

    ETF Analysis: iShares National AMT-Free Muni Bond

    Take an in-depth look at the iShares National AMT-Free Municipal Bond ETF, a highly diverse and very popular muni bond fund.
  7. Mutual Funds & ETFs

    Top 3 Switzerland ETFs

    Explore detailed analysis and information of the top three Swiss exchange-traded funds that offer exposure to the Swiss equities market.
  8. Stock Analysis

    Net Neutrality: Pros and Cons

    The fight over net neutrality has become an amazing spectacle. But at its core, it's yet another skirmish in cable television's war to remain relevant.
  9. Mutual Funds & ETFs

    7 Best ETF Trading Strategies for Beginners

    Exchange-traded funds are ideal instruments for beginning traders and investors. Learn the seven best strategies for trading ETFs.
  10. Mutual Funds & ETFs

    ETF Analysis: SPDR Dow Jones International RelEst

    Learn how the SPDR Dow Jones International Real Estate exchange-traded fund (ETF) is managed and for whom the ETF is most appropriate.
  1. Equity

    The value of an asset less the value of all liabilities on that ...
  2. Exchange-Traded Fund (ETF)

    A security that tracks an index, a commodity or a basket of assets ...
  3. Exchange-Traded Mutual Funds (ETMF)

    Investopedia explains the definition of exchange-traded mutual ...
  4. Hard-To-Sell Asset

    An asset that is extremely difficult to dispose of either due ...
  5. Sucker Yield

    When an investor has essentially risked all of his capital for ...
  6. Lion economies

    A nickname given to Africa's growing economies.
  1. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  2. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  3. What does a high turnover ratio signify for an investment fund?

    If an investment fund has a high turnover ratio, it indicates it replaces most or all of its holdings over a one-year period. ... Read Full Answer >>
  4. Does index trading increase market vulnerability?

    The rise of index trading may increase the overall vulnerability of the stock market due to increased correlations between ... Read Full Answer >>
  5. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  6. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>

You May Also Like

Trading Center

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!